Study on the Effect of Atezolizumab Combined with Bevacizumab after Radical Resection in the Treatment of Hepatocellular Carcinoma

医学 贝伐单抗 肝细胞癌 阿替唑单抗 养生 不利影响 内科学 存活率 外科 随机对照试验 癌 泌尿科 胃肠病学 肿瘤科 化疗 癌症 免疫疗法 彭布罗利珠单抗
作者
Xuemei Wang,Beilei Su,Yue Chen
出处
期刊:Indian Journal of Pharmaceutical Sciences [Medknow]
卷期号:85 (S6)
标识
DOI:10.36468/pharmaceutical-sciences.spl.803
摘要

To investigate the efficacy of the addition of atezolizumab combined with bevacizumab after radical resection in the treatment of hepatocellular carcinoma. This was a randomized controlled trial in which 84 patients with hepatocellular carcinoma treated with radical resection were enrolled. 43 patients were randomly assigned to receive trans catheter arterial chemoembolization and were classified as the control group (group C); the other 41 patients were randomly assigned to receive atezolizumab combined with bevacizumab treatment and were classified as research group (group R). Overall survival, recurrence-free survival, objective response rate, and the incidence of adverse events were compared between the two groups. In group R and group C, the median follow-up period was 8.6 mo and 8.2 mo, respectively. In comparison to group C, group R had significantly higher overall survival, recurrencefree survival, and risk ratio (p<0.05). The rate of negative reactions was greater in group R compared to group C (p<0.05). After radical resection of hepatocellular carcinoma, the addition of atezolizumab in combination with bevacizumab to transcatheter arterial chemoembolization significantly improves patients overall survival and recurrence-free survival with a high objective remission rate; however, this dosing regimen leads to a higher number of adverse effects, which need to be paid attention to.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
李爱国的应助被mlg1552003采纳,获得10
1秒前
HJJHJH发布了新的文献求助10
1秒前
Young发布了新的文献求助20
1秒前
纯真的安萱完成签到 ,获得积分10
2秒前
pl完成签到,获得积分10
2秒前
风格化橙发布了新的文献求助10
2秒前
子时月完成签到,获得积分20
2秒前
李爱国的应助被abc37采纳,获得10
2秒前
kl完成签到 ,获得积分10
2秒前
嘻嘻哈哈的应助被hana采纳,获得10
3秒前
汉堡包的应助被二马三乡采纳,获得10
3秒前
3秒前
4秒前
顾矜的应助被伶俐的灵珊采纳,获得10
4秒前
搜集达人的应助被唐唐采纳,获得10
4秒前
11122发布了新的文献求助10
4秒前
Ending完成签到,获得积分10
4秒前
CLOUD发布了新的文献求助10
4秒前
4秒前
碎觉觉发布了新的文献求助10
4秒前
yin完成签到,获得积分10
5秒前
5秒前
5秒前
5秒前
搜集达人的应助被专注以筠采纳,获得10
5秒前
球球帮我找找文献完成签到,获得积分10
5秒前
健忘绮南给健忘绮南的求助进行了留言
5秒前
合适南霜发布了新的文献求助10
5秒前
嘟嘟完成签到,获得积分10
6秒前
SibetHu发布了新的文献求助10
6秒前
ZUOSG发布了新的文献求助10
6秒前
Lucas的应助被科研通管家采纳,获得10
6秒前
子时月发布了新的文献求助20
6秒前
SciGPT的应助被科研通管家采纳,获得10
6秒前
wanci的应助被asss采纳,获得10
6秒前
6秒前
小马甲的应助被科研通管家采纳,获得10
7秒前
感动赛君发布了新的文献求助10
7秒前
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175943
求助须知:如何正确求助?哪些是违规求助? 9567501
关于积分的说明 21793186
捐赠科研通 7770490
什么是DOI,文献DOI怎么找? 3431935
关于科研通互助平台的介绍 2556294
邀请新用户注册赠送积分活动 2477485